Invention Grant
- Patent Title: Vaccines for serogroup X meningococcus
-
Application No.: US14407987Application Date: 2013-06-14
-
Publication No.: US10376573B2Publication Date: 2019-08-13
- Inventor: Mariagrazia Pizza , Peter Dull , Marzia Monica Giuliani , Muhamed-Kheir Taha , Eva Hong , Ala-Eddine Deghmane
- Applicant: GlaxoSmithKline Biologicals SA , Institut Pasteur
- Applicant Address: BE Rixensart FR Paris
- Assignee: GlaxoSmithKline Biologicals SA,Institut Pasteur
- Current Assignee: GlaxoSmithKline Biologicals SA,Institut Pasteur
- Current Assignee Address: BE Rixensart FR Paris
- Agency: Morrison & Foerster LLP
- International Application: PCT/IB2013/054886 WO 20130614
- International Announcement: WO2013/186753 WO 20131219
- Main IPC: A61K39/095
- IPC: A61K39/095 ; A61K39/39 ; A61K39/00
Abstract:
A method for immunizing a subject against serogroup X meningococcus by administering a vaccine comprising one, two or all three of: (i) a meningococcal fHbp antigen; (ii) a meningococcal NHBA antigen; and/or (iii) a meningococcal NadA antigen. The vaccine may also include meningococcal outer membrane vesicles.
Public/Granted literature
- US20160166674A1 VACCINES FOR SEROGROUP X MENINGOCOCCUS Public/Granted day:2016-06-16
Information query
